FSA Advisors’s Innovator US Equity Buffer ETF November BNOV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$934K Sell
19,536
-440
-2% -$20.5K 0.43% 74
2026
Q1
$859K Buy
19,976
+760
+4% +$33.7K 0.57% 58
2025
Q4
$854K Buy
19,216
+3,692
+24% +$162K 0.59% 56
2025
Q3
$675K Hold
15,524
0.53% 62
2025
Q2
$640K Buy
15,524
+808
+5% +$31.4K 0.52% 64
2025
Q1
$562K Buy
14,716
+6,657
+83% +$262K 0.45% 74
2024
Q4
$307K Hold
8,059
0.38% 91
2024
Q3
$307K Sell
8,059
-120
-1% -$4.52K 0.31% 98
2024
Q2
$306K Hold
8,179
0.32% 95
2024
Q1
$298K Sell
8,179
-157
-2% -$5.6K 0.32% 90
2023
Q4
$291K Buy
+8,336
New +$279K 0.36% 81

Other funds holding BNOV

FSA Advisors's BNOV Position: Q2 2026 in Review

FSA Advisors reduced its Innovator US Equity Buffer ETF November (BNOV) stake by 2.2% in Q2 2026, selling an estimated $20.5K and leaving 19,536 shares worth $934K. The position accounts for 0.43% of the portfolio, ranked #74.

FSA Advisors first reported a position in BNOV in Q4 2023 and has held it in 11 quarters since. 93 funds tracked by Wall St. Rank hold BNOV as of Q2 2026.

  • FSA Advisors held 19,536 shares of Innovator US Equity Buffer ETF November worth $934K as of Q2 2026.
  • FSA Advisors sold 440 Innovator US Equity Buffer ETF November shares in Q2 2026, an estimated $20.5K.
  • Innovator US Equity Buffer ETF November made up 0.43% of FSA Advisors's portfolio in Q2 2026, its #74 holding.
  • FSA Advisors first reported a position in Innovator US Equity Buffer ETF November in Q4 2023 and has held it in 11 quarters since.
  • 93 funds tracked by Wall St. Rank held Innovator US Equity Buffer ETF November as of Q2 2026.

Based on FSA Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.